Physician

Matthew Reed Green, MD

According to 2025 Medicare claims, Matthew Green, MD (NPI: 1629210992) practices dermatology in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is CENTRAL WYOMING SKIN CLINIC PC (NPI: 1588851547; TIN: 83-0323797) and primary practice location at 82609-2062.

Green's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,305 traditional Medicare patients, billed 4,740 HCPCS/CPT codes, and received $424,693 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 536 prescription claims across 229 beneficiaries totaling $255,463 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 14 records totaling $308. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $140,728 to $424,693. Similarly, Part D prescription costs have risen steadily, from $33,147 to $255,463. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$232K$464K2015 Medicare payment: $140,728 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $156,408 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $197,031 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $252,255 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $281,477 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $246,700 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $281,051 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $435,558 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $463,603 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $424,693 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155922,385$140,728
20167052,791$156,408
20176922,717$197,031
20188363,200$252,255
20199143,292$281,477
20208473,118$246,700
20219653,449$281,051
20221,3804,673$435,558
20231,2994,950$463,603
20241,3054,740$424,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$128K$255K2015 Drug cost: $33,147 (USD; Tot_Drug_Cst)2016 Drug cost: $23,942 (USD; Tot_Drug_Cst)2017 Drug cost: $41,011 (USD; Tot_Drug_Cst)2018 Drug cost: $22,305 (USD; Tot_Drug_Cst)2019 Drug cost: $71,235 (USD; Tot_Drug_Cst)2020 Drug cost: $99,027 (USD; Tot_Drug_Cst)2021 Drug cost: $108,791 (USD; Tot_Drug_Cst)2022 Drug cost: $230,112 (USD; Tot_Drug_Cst)2023 Drug cost: $191,855 (USD; Tot_Drug_Cst)2024 Drug cost: $255,463 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595190$33,147
2016154323$23,942
2017136267$41,011
2018144294$22,305
2019161373$71,235
2020183443$99,027
2021163359$108,791
2022180397$230,112
2023179358$191,855
2024229536$255,463

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth325358$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more434498$60
88305Pathology examination of tissue using a microscope, intermediate complexity600924$54
17000Destruction of precancer skin growth, 1 growth271310$39
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more270319$37

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil431,219$3,821
FluocinonideFluocinonide531,799$2,526
Doxycycline HyclateDoxycycline Hyclate34933$1,297
Triamcinolone AcetonideTriamcinolone Acetonide1424,130$1,122
DesonideDesonide17471$1,072

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$308ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Reed Green, MD?

Tedicare shows public-source Medicare data for Matthew Reed Green, MD (NPI 1629210992), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Reed Green, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Reed Green, MD?

Matthew Reed Green, MD is linked to CENTRAL WYOMING SKIN CLINIC PC (billing NPI 1588851547) in the available physician profile data.

Does Matthew Reed Green, MD have Open Payments data?

Matthew Reed Green, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.